Clinical trial Recruiting at 1 site Interventional Ages 21 to 75

Polidocanol foam with or without transdermal Nd:YAG 1064 nm laser for lower‑leg varicose veins

Official title: Comparação da eficácia clínica e estética Entre o Tratamento de Varizes Com Espuma de Polidocanol Associada ou não ao Laser transdérmico: Ensaio clínico Randomizado

Run by Hospital Universitario Pedro Ernesto · NCT07276243 · Data updated 2026-11-12

This trial will test whether adding a transdermal Nd:YAG 1064 nm laser to polidocanol foam sclerotherapy helps close and improve the appearance of lower‑leg varicose veins in adults.

More Varicose Veins of Lower Limb trials

Quick facts

Study typeInterventional
Ages21 Years to 75 Years
SexAll
Enrollment102 (estimated)
SponsorHospital Universitario Pedro Ernesto
Academic / other
Locations1 site (Rio de Janeiro, Rio de Janeiro)
StatusRecruiting
StartedMarch 24, 2026
Main results expectedAugust 30, 2027
Study endsDecember 30, 2027
Registry record updatedMay 5, 2026
Trial IDNCT07276243 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21–75 years with CEAP clinical class 1–3 lower‑limb tributary varicose veins measuring 2.5–4.0 mm on Doppler, vein depth ≤4 mm, competent saphenous vein, BMI <35, and able to give informed consent.

Probably not a fit

Patients with CEAP ≥4, axial reflux requiring prior treatment, tributary veins outside the 2.5–4.0 mm or >4 mm depth criteria, pregnancy or breastfeeding, known polidocanol allergy, recent DVT/PE, uninterruptible anticoagulation, or active skin infection are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, parallel study with blinded outcome assessment comparing polidocanol foam alone to polidocanol foam plus transdermal 1064 nm Nd:YAG laser for lower‑limb tributary varicose veins. After 1:1 randomization, the control arm receives 0.5% polidocanol foam and the intervention arm receives 0.25% polidocanol foam followed by transdermal laser application; a second session is allowed at 30 days if partial occlusion persists. The primary endpoint is venous occlusion at 30 days measured by Doppler ultrasound, with additional follow‑ups and assessments at 30, 90, and 180 days for pigmentation, pain, patient satisfaction, number of sessions, and adverse events. Standardized photographs are taken at baseline and each follow‑up to document aesthetic outcomes.

Why it matters

Potential benefit: If successful, adding the laser could increase early vein closure and improve cosmetic results, potentially reducing the need for repeat treatments.

How similar studies have gone: Foam sclerotherapy and Nd:YAG lasers have shown benefit separately in prior work, but the specific combination of transdermal Nd:YAG with lower‑concentration polidocanol foam is relatively novel and has limited published evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 21 to 75 years
* CEAP clinical class 1-3
* Lower limb tributary varicose veins 2,5 to 4,0 mm in diameter on Doppler ultrasound.
* Vein depth up to 4 mm from the skin surface.
* Tributary vein may originate from the great or small saphenous vein as long as the saphenous vein is competent on Doppler.
* Reflux limited to the target tributary.
* Body mass index (BMI) \< 35 km²/m²
* Able and willing to provide informed consent.

Exclusion Criteria:

* CEAP clinical class ≥ 4
* Axial reflux of the great or small saphenous vein requiring prior treatment
* Tributary vein diameter \< 2.5 mm or \> 4.0 mm on Doppler
* Tributary vein depth \> 4 mm from the skin surface
* Pregnancy or breastfeeding
* Known allergy or hypersensitivity to polidocanol
* History of deep vein thrombosis or pulmonary embolism in the last 6 months
* Use of anticoagulant therapy that cannot be safely interrupted
* Active skin infection or ulcer at the treatment site
* Autoimmune or connective tissue disease with active vasculitis
* BMI ≥ 35 kg/m²
* Inability to comply with follow-up visits
* Previous treatment of the target vein in the past 6 months (laser, foam, surgery, or microphlebectomy).

Where it's running

  • Hospital Universitário Pedro Ernesto - UERJ
    Rio de Janeiro, Rio de Janeiro, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.